Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Among the top significant correlates (Figure 4A) were transcripts previously associated with α cell behavior like GC (vitamin D binding protein) (38) and LOXL4 (lysyl oxidase like 4) (16), with the latter also contributing to immune evasion (39).

Source: Transcripts and pathways linked to T1D α cell function.. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Human islets and dispersed cells were cultured in low glucose (5.5 mM) DMEM (Thermo-Fisher, #11885) with 10% FBS (Thermo-Fisher, #12483020) and 100 U/ml penicillin/streptomycin (Thermo-Fisher, #15070063) at 37°C and 5% CO2 for 1 to 3 days prior to use.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Altered immune and metabolic molecular pathways drive islet cell dysfunction in human type 1 diabetes

Study design awaiting verification · The Journal of Clinical Investigation · 2025

Original publication title

Altered immune and metabolic molecular pathways drive islet cell dysfunction in human type 1 diabetes

Theodore dos Santos; Xiao-Qing Dai; Robert C. Jones; Aliya F. Spigelman; Hannah M. Mummey; Jessica D. Ewald; Cara E. Ellis; James G. Lyon; Nancy Smith; Austin Bautista; Jocelyn E. Manning Fox; Norma F. Neff; Angela M. Detweiler; Michelle Tan; Rafael Arrojo e Drigo; Jianguo Xia; Joan Camunas-Soler; Kyle J. Gaulton; Stephen R. Quake; Patrick E. MacDonald

© 2025 Santos et al.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of most insulin-producing β cells, along with dysregulated glucagon secretion from pancreatic α cells. We conducted an integrated analysis that combines electrophysiological and transcriptomic profiling, along with machine learning, of islet cells from T1D donors. The few surviving β cells exhibit altered electrophysiological properties and transcriptomic signatures indicative of increased antigen presentation, metabolic reprogramming, and impaired protein translation. In α cells, we observed hyperresponsiveness and increased exocytosis, which are associated with upregulated immune signaling, disrupted transcription factor localization, and lysosome homeostasis, as well as dysregulation of mTORC1 complex signaling.

Notably, key genetic risk signals for T1D were enriched in transcripts related to α cell dysfunction, including MHC class I, which were closely linked with α cell dysfunction. Our data provide what we believe are novel insights into the molecular underpinnings of islet cell dysfunction in T1D, highlighting pathways that may be leveraged to preserve residual β cell function and modulate α cell activity. These findings underscore the complex interplay between immune signaling, metabolic stress, and cellular identity in shaping islet cell phenotypes in T1D.

Authors’ abstract

Type 1 diabetes (T1D) is characterized by the autoimmune destruction of most insulin-producing β cells, along with dysregulated glucagon secretion from pancreatic α cells. We conducted an integrated analysis that combines electrophysiological and transcriptomic profiling, along with machine learning, of islet cells from T1D donors. The few surviving β cells exhibit altered electrophysiological properties and transcriptomic signatures indicative of increased antigen presentation, metabolic reprogramming, and impaired protein translation. In α cells, we observed hyperresponsiveness and increased exocytosis, which are associated with upregulated immune signaling, disrupted transcription factor localization, and lysosome homeostasis, as well as dysregulation of mTORC1 complex signaling.

Notably, key genetic risk signals for T1D were enriched in transcripts related to α cell dysfunction, including MHC class I, which were closely linked with α cell dysfunction. Our data provide what we believe are novel insights into the molecular underpinnings of islet cell dysfunction in T1D, highlighting pathways that may be leveraged to preserve residual β cell function and modulate α cell activity. These findings underscore the complex interplay between immune signaling, metabolic stress, and cellular identity in shaping islet cell phenotypes in T1D.

Publication and source details

Original title: Altered immune and metabolic molecular pathways drive islet cell dysfunction in human type 1 diabetes

Theodore dos Santos; Xiao-Qing Dai; Robert C. Jones; Aliya F. Spigelman; Hannah M. Mummey; Jessica D. Ewald; Cara E. Ellis; James G. Lyon; Nancy Smith; Austin Bautista; Jocelyn E. Manning Fox; Norma F. Neff; Angela M. Detweiler; Michelle Tan; Rafael Arrojo e Drigo; Jianguo Xia; Joan Camunas-Soler; Kyle J. Gaulton; Stephen R. Quake; Patrick E. MacDonald

The Journal of Clinical Investigation · 2025

Address correspondence to: Patrick MacDonald, LKS Centre, Rm 6-126, Alberta Diabetes Institute, University of Alberta, Edmonton, Canada, T6G2R3. Email: pmacdonald@ualberta.ca.© 2025 Santos et al.2025Santos et al.https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Canadian Institutes of Health Research186226 National Institutes of Healthhttps://doi.org/10.13039/100000002 DK120447,DK105554,DK138512,HG012059,UC4-DK-112217,U01-DK-123594,UC4-DK-112232,U01-DK-123716Breakthrough T1D2-SRA-2019-698-S-BKnut and Alice Wallenberg Foundationn/aSwedish Research Council2021-05109

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:43:13.572707+00:00

DOI: 10.1172/jci195267 · PMC12646676